FFC#27/2014

Transmissibility and clinical significance of Mycobacterium abscessus in patients with cystic fibrosis

FFC#27/2014

Transmissibility and clinical significance of Mycobacterium abscessus in patients with cystic fibrosis

PRINCIPAL INVESTIGATOR

Enrico Tortoli (Unità Patogeni Batterici Emergenti, Div. di Immunologia, trapianto e Malattie Infettive, Istituto Scientifico San Raffaele, Milano)

Partner

Lisa Cariani (Fondazione IRCSS Ca’ Granda Ospedale Maggiore Policlinico, Milano), Clelia Di Serio (CUSSB-Centro Universitario di Statistica per le Scienze Biomediche, Università Vita-Salute San Raffaele Milano), Stefan Niemann (Molecular Mycobacteriology, Research Center Borstel)

RESEARCHERS

18

CATEGORY

AREA 4 Lung inflammation

DURATION

2 years

GOAL

€ 80.000

RESULTS

306 MA isolated from 62 FC patients of 4 Italian CF centers were studied. In the large majority of patients persistently infected by the same MA, the subspecies genetic analysis was carried out by VNTR profile and/or resorting to whole genome sequencing. It demonstrated that the genotype remained unchanged in the same patient and the same strain of MA was invariably responsible for the infection. In contrast, the isolates from different patients belonged to different strains. Only in a couple of patients, nine strains were shared and the patient-to-patient transmission cannot be excluded. The epidemiological investigation undertaken by the researchers will help to make clear this question. The antimicrobial susceptibility testing confirmed that, with the exception of a single strain, all the others strains were characterized by inducible resistance to macrolides. The confirmation or the exclusion of patient-to-patient transmission may heavily impact on cross-infection prevention measures.

OTHER RESULTS

FFC #3/2024

Two molecules are effective in activating Heat Shock Proteins and enhancing the action of CFTR correctors with the F508del mutation in vitro.

FFC#5/2024

Some peptide nucleic acids (PNAs) re-sensitise Pseudomonas aeruginosa to the antibiotic meropenem in vitro and reduce its virulence.

FFC#1/2023

Tezacaftor, one of the components of Kaftrio, induces an accumulation of dihydroceramides both in vitro and in vivo in animal models